Skip to main content
PMC home page
Nature Communications logoLink to Nature Communications
. 2022 Jan 7;13:294. doi: 10.1038/s41467-021-27678-7

Author Correction: Comprehensive characterization of 536 patient-derived xenograft models prioritizes candidates for targeted treatment

Hua Sun 1,2,#, Song Cao 1,2,#, R Jay Mashl 1,2,#, Chia-Kuei Mo 1,2,#, Simone Zaccaria 3,4,#, Michael C Wendl 2,5,6, Sherri R Davies 1, Matthew H Bailey 7, Tina M Primeau 1, Jeremy Hoog 1, Jacqueline L Mudd 1, Dennis A Dean II 8, Rajesh Patidar 9, Li Chen 9, Matthew A Wyczalkowski 1,2, Reyka G Jayasinghe 1,2, Fernanda Martins Rodrigues 1,2, Nadezhda V Terekhanova 1,2, Yize Li 1,2, Kian-Huat Lim 1,10, Andrea Wang-Gillam 1,10, Brian A Van Tine 1,10, Cynthia X Ma 1,10, Rebecca Aft 10, Katherine C Fuh 1,10, Julie K Schwarz 10,11, Jose P Zevallos 10,12, Sidharth V Puram 10,12, John F Dipersio 1,10; The NCI PDXNet Consortium, Brandi Davis-Dusenbery 8, Matthew J Ellis 13, Michael T Lewis 13, Michael A Davies 14, Meenhard Herlyn 15, Bingliang Fang 14, Jack A Roth 14, Alana L Welm 7, Bryan E Welm 7, Funda Meric-Bernstam 14, Feng Chen 1, Ryan C Fields 10, Shunqiang Li 1,10, Ramaswamy Govindan 1,10, James H Doroshow 16, Jeffrey A Moscow 17, Yvonne A Evrard 9, Jeffrey H Chuang 18, Benjamin J Raphael 3, Li Ding 1,2,6,10,✉
PMCID: PMC8742097  PMID: 34996889

Correction to: Nature Communications 10.1038/s41467-021-25177-3, published online 24 August 2021.

In this Article the Competing interests statement inadvertently omitted a statement for M.T.L. and L.E.D. The competing financial interests for M.T.L. should have read: ‘M.T.L. is a founder and limited partner in StemMed Ltd. and a manager in StemMed Holdings, its general partner. He is a founder and equity stakeholder in Tvardi Theraeutics Inc. Some PDXs are exclusively licensed to StemMed Ltd. resulting in royalty income to M.T.L.’. The competing financial interests for L.E.D. should have read, ‘L.E.D. is a compensated employee of StemMed Ltd’. The PDF and HTML versions of the Article have been corrected.

Contributor Information

Li Ding, Email: lding@wustl.edu.

The NCI PDXNet Consortium:

Julie Belmar, Jason Held, Jingqin Luo, Brian A. Van Tine, Rose Tipton, Yige Wu, Lijun Yao, Daniel Cui Zhou, Andrew Butterfield, Zhengtao Chu, Maihi Fujita, Chieh-Hsiang Yang, Emilio Cortes-Sanchez, Sandra Scherer, Ling Zhao, Tijana Borovski, Vicki Chin, John DiGiovanna, Christian Frech, Jeffrey Grover, Ryan Jeon, Soner Koc, Jelena Randjelovic, Sara Seepo, Tamara Stankovic, Lacey E. Dobrolecki, Michael Ittmann, Susan G. Hilsenbeck, Bert W. O’Malley, Nicholas Mitsiades, Salma Kaochar, Argun Akcakanat, Jithesh Augustine, Huiqin Chen, Bingbing Dai, Kurt W. Evans, Kelly Gale, Don Gibbons, Min Jin Ha, Vanessa Jensen, Michael Kim, Bryce P. Kirby, Scott Kopetz, Christopher D. Lanier, Dali Li, Mourad Majidi, David Menter, Ismail Meraz, Turcin Saridogan, Stephen Scott, Alexey Sorokin, Coya Tapia, Jing Wang, Shannon Westin, Yuanxin Xi, Yi Xu, Fei Yang, Timothy A. Yap, Vashisht G. Yennu-Nanda, Erkan Yuca, Jianhua Zhang, Ran Zhang, Xiaoshan Zhang, Xiaofeng Zheng, Dylan Fingerman, Haiyin Lin, Qin Liu, Andrew V. Kossenkov, Vito W. Rebecca, Rajasekharan Somasundaram, Michae T. Tetzlaff, Jayamanna Wickramasinghe, Min Xiao, Xiaowei Xu, Carol J. Bult, Peter N. Robinson, Anuj Srivastava, Michael W. Lloyd, Steven B. Neuhauser, Jill Rubinstein, Brian J. Sanderson, Brian White, Xing Yi Woo, Tiffany Wallace, John D. Minna, Gao Boning, Luc Girard, Hyunsil Park, Brenda C. Timmons, Katherine L. Nathanson, George Xu, Chong-xian Pan, Moon S. Chen Jr, Luis G. Carvajal-Carmona, May Cho, Nicole B. Coggins, Ralph W. deVere White, Guadalupe Polanco-Echeverry, Ana Estrada, David R. Gandara, Amanda R. Kirane, Tiffany Le, Paul Lott, Alexa Morales Arana, Jonathan W. Reiss, Sienna Rocha, Clifford G. Tepper, Ted Toal, Hongyong Zhang, and Ai-Hong Ma

Articles from Nature Communications are provided here courtesy of Nature Publishing Group

RESOURCES